These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 17608585)

  • 1. RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis.
    Jin Q; Cirelli JA; Park CH; Sugai JV; Taba M; Kostenuik PJ; Giannobile WV
    J Periodontol; 2007 Jul; 78(7):1300-8. PubMed ID: 17608585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.
    Li X; Ominsky MS; Stolina M; Warmington KS; Geng Z; Niu QT; Asuncion FJ; Tan HL; Grisanti M; Dwyer D; Adamu S; Ke HZ; Simonet WS; Kostenuik PJ
    Bone; 2009 Oct; 45(4):669-76. PubMed ID: 19539794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cimetidine reduces alveolar bone loss in induced periodontitis in rat molars.
    Longhini R; Aparecida de Oliveira P; Sasso-Cerri E; Cerri PS
    J Periodontol; 2014 Aug; 85(8):1115-25. PubMed ID: 24283656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Cachaça, a typical Brazilian alcoholic beverage, on alveolar bone loss and density: a study in peripubertal rats.
    Bastos MF; Gaag GL; Romero JR; Gabrili JJ; Marques MR; Duarte PM
    Arch Oral Biol; 2014 Jan; 59(1):82-91. PubMed ID: 24183604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease.
    Valverde P; Kawai T; Taubman MA
    J Bone Miner Res; 2004 Jan; 19(1):155-64. PubMed ID: 14753747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis.
    Crotti T; Smith MD; Hirsch R; Soukoulis S; Weedon H; Capone M; Ahern MJ; Haynes D
    J Periodontal Res; 2003 Aug; 38(4):380-7. PubMed ID: 12828654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor activator of nuclear factor kappa B ligand antagonists inhibit tissue inflammation and bone loss in experimental periodontitis.
    Yuan H; Gupte R; Zelkha S; Amar S
    J Clin Periodontol; 2011 Nov; 38(11):1029-36. PubMed ID: 22092474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of 5-hydroxytryptophan aggravated periodontitis-induced alveolar bone loss in rats.
    Li X; Wu X; Ma Y; Hao Z; Chen S; Fu T; Chen H; Wang H
    Arch Oral Biol; 2015 May; 60(5):789-98. PubMed ID: 25766472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E(2) is a main mediator in receptor activator of nuclear factor-kappaB ligand-dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii.
    Choi BK; Moon SY; Cha JH; Kim KW; Yoo YJ
    J Periodontol; 2005 May; 76(5):813-20. PubMed ID: 15898943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local delivery of osteoprotegerin inhibits mechanically mediated bone modeling in orthodontic tooth movement.
    Dunn MD; Park CH; Kostenuik PJ; Kapila S; Giannobile WV
    Bone; 2007 Sep; 41(3):446-55. PubMed ID: 17588510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo osteoprotegerin gene therapy preventing bone loss induced by periodontitis.
    Tang H; Mattheos N; Yao Y; Jia Y; Ma L; Gong P
    J Periodontal Res; 2015 Aug; 50(4):434-43. PubMed ID: 25203865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boric acid inhibits alveolar bone loss in rats by affecting RANKL and osteoprotegerin expression.
    Sağlam M; Hatipoğlu M; Köseoğlu S; Esen HH; Kelebek S
    J Periodontal Res; 2014 Aug; 49(4):472-9. PubMed ID: 24033134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of ligature-induced experimental periodontitis.
    de Molon RS; Park CH; Jin Q; Sugai J; Cirelli JA
    Microsc Res Tech; 2018 Dec; 81(12):1412-1421. PubMed ID: 30351474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice.
    de Molon RS; Shimamoto H; Bezouglaia O; Pirih FQ; Dry SM; Kostenuik P; Boyce RW; Dwyer D; Aghaloo TL; Tetradis S
    J Bone Miner Res; 2015 Sep; 30(9):1627-40. PubMed ID: 25727550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local osteoprotegerin gene transfer to periodontal tissue inhibits lipopolysaccharide-induced alveolar bone resorption.
    Chen R; Kanzaki H; Chiba M; Nishimura M; Kanzaki R; Igarashi K
    J Periodontal Res; 2008 Apr; 43(2):237-45. PubMed ID: 18086145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting RANKL for reduction of bone loss around unstable implants: OPG-Fc compared to alendronate in a model for mechanically induced loosening.
    Aspenberg P; Agholme F; Magnusson P; Fahlgren A
    Bone; 2011 Feb; 48(2):225-30. PubMed ID: 20858557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPAR-gamma agonist rosiglitazone prevents inflammatory periodontal bone loss by inhibiting osteoclastogenesis.
    Hassumi MY; Silva-Filho VJ; Campos-Júnior JC; Vieira SM; Cunha FQ; Alves PM; Alves JB; Kawai T; Gonçalves RB; Napimoga MH
    Int Immunopharmacol; 2009 Sep; 9(10):1150-8. PubMed ID: 19508902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis.
    Lu HK; Chen YL; Chang HC; Li CL; Kuo MY
    J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio.
    Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Atilla G; Hughes FJ; Belibasakis GN
    J Clin Periodontol; 2007 May; 34(5):370-6. PubMed ID: 17355365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoprotegerin-deficient male mice as a model for severe alveolar bone loss: comparison with RANKL-overexpressing transgenic male mice.
    Koide M; Kobayashi Y; Ninomiya T; Nakamura M; Yasuda H; Arai Y; Okahashi N; Yoshinari N; Takahashi N; Udagawa N
    Endocrinology; 2013 Feb; 154(2):773-82. PubMed ID: 23291450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.